Archives

by in
Entry Author Date Location
Agios Files For IPO With Plans to Raise $86M 06/11/13 Boston
Epizyme Soars 50 Percent in IPO Debut 05/31/13 Boston
Epizyme Prices IPO at $15 Per Share, Begins Trading Friday 05/30/13 Boston
NanoString Technologies Maneuvers In Line for $86M IPO 05/20/13 Seattle
Living Proof Receives $30,000,000 New Financing Round 02/22/13 Boston
With $30M in Financing, Living Proof Primps for More Good Hair Days 02/21/13 Boston
UnitedHealth Unit Buys Boston Health IT Firm Humedica 01/25/13 Boston
Who Are Biotech’s New Go-To Investment Bankers? 11/12/12 National
Radius Fourth Boston-area Biotech This Year Going for IPO 10/24/12 Boston
In Wake of Alzheimer’s Disaster, Wall Street Revisits Pfizer and J&J 08/08/12 New York
Radius Health Seeks $86M IPO 02/07/12 Boston
Avila, iRobot, Verastem, Illume, & More Boston Deal News 02/01/12 Boston
Verastem Bucks the Trend, Raises $55M in IPO 01/26/12 Boston
Amicus Counts on “Chaperone” Tech to Enhance Rare Disease Treatments 01/11/12 New York
Verastem, the 15-Month Old Christoph Westphal Venture in Cancer Stem Cells, Seeks IPO 11/03/11 Boston
Biogen Eyes Cambridge Move, Vertex Licenses Alios Drugs, Concert Nabs GSK Payment, & More Boston-Area Life Sciences News 06/24/11 Boston
Nuance Buys SVOX, Aveo Sells $100M in Stock, CSN Grabs $165M, & More Boston-Area Deals News 06/22/11 Boston
Tesaro Snags Huge $101M Venture Round to Develop Cancer Drugs 06/21/11 Boston
Anthera Raises $47M 06/03/11 San Francisco
eBay Acquires Where, Bluebird Calls In $30M, Humedica Gets $20M, & More Boston-Area Deals News 04/27/11 Boston
Ariad Extends Licenses, Amgen Osteoporosis Drug Meets Trial Goals, Corindus Partners with Philips, & More Boston-Area Life Sciences News 04/22/11 Boston
Humedica Lands $20M Round 04/20/11 Boston
Seattle Genetics Reloads Cash Reserves With $155M, On Cusp of Selling First Drug 02/02/11 Seattle
Alkermes CEO Leans on Internal Pipeline as Bydureon Hangs Out in the Penalty Box 11/15/10 Boston
Ambit Biosciences Seeks $86M IPO as Market Warms Up 11/08/10 San Diego
Alnylam Seeks to Prove RNAi Skeptics Wrong After Layoffs, End of Novartis Deal 10/21/10 Boston
RainDance Technologies, Delving Deep into DNA, Gets Wall Street Connections with Latest CEO 07/27/10 Boston
How Much Would You Pay for Genzyme? 07/26/10 Boston
Vivus Faces Turning Point in Obesity Drug Battle Tomorrow With Arena, Orexigen 07/14/10 San Francisco
Athenahealth Paying Dearly to Take on Larger Rivals 05/06/10 Boston
Page 1 of 2 next page »

Xconomy Events Across the Network

XSITE 2013: Boston’s Tech Revival

Boston · 6/19/13
9:00 am

More Xconomy Events

Xconomy’s Most Popular

  1. Don’t Panic, But We’ve Passed Peak Apple. And Google. And Facebook.
  2. With Big Bucks Chasing Big Data, Will Consumers Get a Cut?
  3. Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian
  4. 11 Reasons Why Flickr, Not Facebook, Is the Place to Put Your Photos
  5. Digital Lumens, Finding Its Identity, Brings Cost & Energy Savings to Light

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.